Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) on Friday, plunged -3.52% from the previous trading day, before settling in for the closing price of $42.36. Within the past 52 weeks, TNXP’s price has moved between $6.76 and $130.00.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 73.03%. The company achieved an average annual earnings per share of 93.08%. With a float of $7.35 million, this company’s outstanding shares have now reached $7.36 million.
The extent of productivity of a business whose workforce counts for 81 workers is very important to gauge. In terms of profitability, gross margin is 29.81%, operating margin of -721.51%, and the pretax margin is -1146.27%.
Tonix Pharmaceuticals Holding Corp (TNXP) Insider Updates
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Tonix Pharmaceuticals Holding Corp is 0.07%, while institutional ownership is 6.77%. The most recent insider transaction that took place on May 15 ’25, was worth 86,200. In this transaction Chief Executive Officer of this company bought 4,000 shares at a rate of $21.55, taking the stock ownership to the 4,005 shares.
Tonix Pharmaceuticals Holding Corp (TNXP) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 93.08% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 88.07% during the next five years compared to 73.03% growth over the previous five years of trading.
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) Trading Performance Indicators
Tonix Pharmaceuticals Holding Corp (TNXP) is currently performing well based on its current performance indicators. A quick ratio of 11.64 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 29.95.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2930.78, a number that is poised to hit -5.18 in the next quarter and is forecasted to reach -6.08 in one year’s time.
Technical Analysis of Tonix Pharmaceuticals Holding Corp (TNXP)
The latest stats from [Tonix Pharmaceuticals Holding Corp, TNXP] show that its last 5-days average volume of 0.68 million was inferior to 1.27 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 85.81%.
During the past 100 days, Tonix Pharmaceuticals Holding Corp’s (TNXP) raw stochastic average was set at 90.86%, which indicates a significant increase from 77.43% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 2.66 in the past 14 days, which was lower than the 2.85 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $31.73, while its 200-day Moving Average is $22.77. Now, the first resistance to watch is $42.46. This is followed by the second major resistance level at $44.04. The third major resistance level sits at $45.84. If the price goes on to break the first support level at $39.08, it is likely to go to the next support level at $37.28. Assuming the price breaks the second support level, the third support level stands at $35.70.
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) Key Stats
Market capitalization of the company is 300.69 million based on 7,357K outstanding shares. Right now, sales total 10,090 K and income totals -130,040 K. The company made 2,430 K in profit during its latest quarter, and -16,830 K in sales during its previous quarter.
